Yükleniyor... / Loading...
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
Bu gözlemsel çalışma, bipolar bozukluk (bipolar disorder) açısından yüksek riskli bireylerde hastalığın gelişimini öngörmeye yönelik bir tahmin modeli oluşturmayı amaçlamaktadır. Çalışmaya, en az bir ebeveyni bipolar bozukluk tanısı almış 6-18 yaş arası çocuklar, atipik depresyon tanısı olan bireyler ve yaş ile cinsiyet açısından eşleştirilmiş sağlıklı kontroller katılabilir. Çalışma faz uygulanmayan bir çalışma olup halen katılımcı almaktadır.
Yukarıdaki özet, resmî kaydın sade dile aktarılmış halidir. Orijinal İngilizce başlık referans için gösterilir.
Kriterler ClinicalTrials.gov kaydından orijinal İngilizce haliyle alınmıştır. Uygunluk kararını yalnızca deneyi yürüten ekip verebilir.
Inclusion Criteria: * High-risk offsprings of parents with BD: Aged 6-18 yrs, both male and female. Offsprings and parents can sign the writtened informed consent form. At least one of parents was diagnosed with bipolar disorder by two or more senior psychiatric doctor. * Atypical depression: Aged 6-18 yrs, both male and female. Patients and parents can sign the writtened informed consent form. Patients was diagnosed with atypical depression by two or more senior psychiatric doctor according to DSM-5. The disease phase and treatment regime are unrestricted. * Health control: health individuals with age and gender matched with high-risk offsprings, no psychiatric family history. Exclusion Criteria: * High-risk offsprings of parents with BD: HCL-32 total score \> 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. * Atypical depression: HCL-32 total score \> 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. Patients cormobid substance abuse or treated with MECT in recent half a year. * Health control: Individuals with psychiatric family history, severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.